United States - English - NLM (National Library of Medicine)

xspire pharma, llc - caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e), butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - caffeine 40 mg - butalbital, acetaminophen and caffeine capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. caution in this regard is required because butalbital is habit-forming and potentially abusable. this product is contraindicated under the following conditions: - hypersensitivity or intolerance to any component of this product - patients with porphyria butalbital barbiturates may be habit-forming: tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. the average daily dose for the barbiturate addict is usually about 1500 mg. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fatal dosage, however, does not increase more than two-fold. as this occurs, the margin between an in

United States - English - NLM (National Library of Medicine)

armas pharmaceuticals inc. - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate injection is indicated for the treatment of apnea of prematurity. caffeine citrate injection is contraindicated in patients who have demonstrated hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

micro labs limited - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine  citrate is indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components. caffeine citrate oral solution each bottle (vial) of caffeine citrate oral solution contains a total of 60 mg of caffeine citrate in 3 ml (20 mg/ml). information and instructions for use this leaflet tells you about caffeine citrate oral solution (kaf-een sit-rate) and how to give it to your baby.  read the following information before giving this medicine to your baby.  completely discuss caffeine citrate oral solution with your baby’s doctor.  continue to discuss any questions you have about this medicine at your baby’s checkups. after you remove your baby’s dose, throw away the open bottle (vial) and all medicine left in it .  use each vial of caffeine citrate oral solution for only one dose.  there will be extra medicine left in the vial after one dose is remo

United States - English - NLM (National Library of Medicine)

armas pharmaceuticals inc. - caffeine citrate (unii: u26eo4675q) (caffeine - unii:3g6a5w338e) - caffeine citrate is indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age. caffeine citrate is contraindicated in patients who have demonstrated hypersensitivity to any of its components. caffeine citrate oral solution each bottle (vial) of caffeine citrate oral solution contains a total of 60 mg of caffeine citrate in 3 ml (20 mg/ml). information and instructions for use this leaflet tells you about caffeine citrate oral solution (kaf-een sit-rate) and how to give it to your baby.  read the following information before giving this medicine to your baby.  completely discuss caffeine citrate oral solution with your baby’s doctor.  continue to discuss any questions you have about this medicine at your baby’s checkups. after you remove your baby’s dose, throw away the open bottle (vial) and all medicine left in it .  use each vial of caffeine citrate oral solution for only one dose.  there will be extra medicine left in the vial after one dose is remov

Canada - English - Health Canada

omega laboratories limited - caffeine citrate - solution - 20mg - caffeine citrate 20mg

Canada - English - Health Canada

omega laboratories limited - caffeine citrate - solution - 20mg - caffeine citrate 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - caffeine citrate - solution for infusion - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - caffeine citrate - oral solution - 10mg/1ml

Malta - English - Medicines Authority

chefaro ireland dac the sharp building, hogan place, dublin 2,, ireland - caffeine, paracetamol, codeine phosphate, hemihydrate - hard capsule - caffeine 30 mg paracetamol 500 mg codeine phosphate hemihydrate 8 mg - analgesics

Canada - English - Health Canada

added dimensions - caffeine - tablet - 200mg - caffeine 200mg - respiratory and cns stimulants